$100 Invested In This Stock 10 Years Ago Would Be Worth $400 Today

7/9/24 3:00:33 PM ET

Medical/Dental Instruments

Health Care

Get the next $SYK alert in real time by email

Stryker (NYSE:SYK) has outperformed the market over the past 10 years by 4.1% on an annualized basis producing an average annual return of 15.02%. Currently, Stryker has a market capitalization of $127.79 billion.

Buying $100 In SYK: If an investor had bought $100 of SYK stock 10 years ago, it would be worth $401.97 today based on a price of $335.44 for SYK at the time of writing.

Stryker's Performance Over Last 10 Years

comp_fig

Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Get the next $SYK alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$SYK

Date	Price Target	Rating	Analyst
9/10/2024	$405.00	Outperform	Wolfe Research
5/30/2024	$372.00	Neutral	Goldman
5/22/2024	$392.00	Hold → Buy	Needham
1/31/2024	$315.00 → $360.00	Hold → Buy	Canaccord Genuity
10/20/2023	$345.00	Buy	ROTH MKM
9/5/2023	$310.00 → $315.00	Neutral → Buy	BofA Securities
3/29/2023	$287.00	Neutral	UBS
1/25/2023		Sector Weight	KeyBanc Capital Markets

More analyst ratings

$SYK
Press Releases

Fastest customizable press release news feed in the world

Stryker unveils Oculan Lighting Platform to enhance surgical visualization and illumination
FLOWER MOUND, Texas, USA, Nov. 19, 2024 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, unveiled the Oculan Lighting Platform, an innovative lighting solution designed to provide consistent, high-quality illumination, allowing surgeons to focus on delivering the highest standard of care. In today's operating rooms, where precision and accuracy are critical, even the smallest challenges may impact surgical outcomes – factors which may impede a surgeon's ability to see clearly and work efficiently. "The Oculan Lighting Platform was developed in respo
11/19/24 9:05:00 AM ET
$SYK
Medical/Dental Instruments
Health Care
Stryker launches next generation of SurgiCount+ to help improve the standard of care in hospitals for sponge management and blood loss assessment
PORTAGE, Mich., USA, Nov. 14, 2024 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, announced its launch of the next generation of SurgiCount+ within its sponge management portfolio. Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals. Maternal mortality has been rising in the U.S. for decades,1 with approximately 50,000 c
11/14/24 9:05:00 AM ET
$SYK
Medical/Dental Instruments
Health Care
Stryker reports third quarter 2024 operating results
Portage, Michigan, Oct. 29, 2024 (GLOBE NEWSWIRE) -- reported operating results for the third quarter of 2024: Third Quarter Results Reported net sales increased 11.9% to $5.5 billionOrganic net sales increased 11.5%Reported operating income margin of 19.7%Adjusted operating income margin(1) increased 130 bps to 24.7%Reported EPS increased 20.0% to $2.16Adjusted EPS(1) increased 16.7% to $2.87 Third Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures OrganicMedSurg and Neurotechnology 12.8 % (0.1) % 12.9 % 0.2 % 12.7 %Orthopaedics and Spine 10.7
10/29/24 4:05:00 PM ET
$SYK
Medical/Dental Instruments
Health Care

$SYK
Financials

Live finance-specific insights

Stryker reports third quarter 2024 operating results
Portage, Michigan, Oct. 29, 2024 (GLOBE NEWSWIRE) -- reported operating results for the third quarter of 2024: Third Quarter Results Reported net sales increased 11.9% to $5.5 billionOrganic net sales increased 11.5%Reported operating income margin of 19.7%Adjusted operating income margin(1) increased 130 bps to 24.7%Reported EPS increased 20.0% to $2.16Adjusted EPS(1) increased 16.7% to $2.87 Third Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures OrganicMedSurg and Neurotechnology 12.8 % (0.1) % 12.9 % 0.2 % 12.7 %Orthopaedics and Spine 10.7
10/29/24 4:05:00 PM ET
$SYK
Medical/Dental Instruments
Health Care
Stryker completes acquisition of Vertos Medical, Inc., expanding interventional pain management solutions
Portage, Michigan, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today that it has completed the acquisition of Vertos Medical Inc., a leader in interventional pain management solutions for chronic lower back pain caused by lumbar spinal stenosis. "The acquisition of Vertos Medical enhances our unique, non-surgical solutions for interventionalists addressing chronic lower back pain, while broadening our presence in ambulatory surgery centers," said Andy Pierce, Group President, MedSurg and Neurotechnology, Stryker. "We look forward to enabling physicians with the minimally invasive mild® procedure so patients can reclaim their quality of life." The addition of Vertos Me
10/1/24 8:00:00 AM ET
$SYK
Medical/Dental Instruments
Health Care
Stryker completes acquisition of NICO Corporation, expanding minimally invasive solutions for brain tumor removal and stroke care
PORTAGE, Mich., USA, Sept. 20, 2024 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, announced today that it has completed the acquisition of NICO Corporation, a privately held company providing a systematic approach to minimally invasive surgery for tumor and intracerebral hemorrhage (ICH) procedures. This acquisition further strengthens Stryker's commitment to neurotechnology through tumor and stroke care. ICH, or bleeding in the brain caused by a ruptured blood vessel, is the deadliest form of stroke, affecting over 3.4 million people annually ar
9/20/24 8:00:00 AM ET
$SYK
Medical/Dental Instruments
Health Care

$SYK
Leadership Updates

Live Leadership Updates

Masimo Appoints Timothy Scannell and Wendy Lane to Board of Directors
Mr. Scannell and Ms. Lane will Add Valuable Medical Technology, Finance and Corporate Governance Experience to Expanded Eight-Member Board Masimo Corporation (NASDAQ:MASI), a leading global medical innovator, today announced the appointments of Timothy J. Scannell and Wendy E. Lane to the Company's Board of Directors (the "Board"), effective immediately. Following these appointments, the Board will consist of eight directors. Quentin Koffey, Lead Independent Director of Masimo, stated, "We are pleased to welcome Tim and Wendy as our newest independent directors. Both are high-caliber professionals who will bring critical perspectives to the Board and possess expertise that closely aligns
10/18/24 9:00:00 AM ET
$ENV
$LH
$MASI
$MSCI
Business Services
Consumer Discretionary
Medical Specialities
Health Care
Eko Health Announces Appointment of Brent Lang, Former CEO of Vocera, to Board of Directors
EMERYVILLE, Calif., Sept. 12, 2024 /PRNewswire/ -- Eko Health, a pioneer in applying artificial intelligence (AI) for early detection of heart and lung diseases, today announced the appointment of Brent D. Lang, former Chairman and CEO of Vocera Communications, to its Board of Directors. Lang brings over three decades of healthcare and technology experience, having led Vocera through rapid growth, a successful IPO, and its $3 billion acquisition by Stryker (NYSE:SYK). His strategic vision and proven leadership will guide Eko as it continues to innovate and expand its platform
9/12/24 10:00:00 AM ET
$SYK
Medical/Dental Instruments
Health Care
Politan Details Why a Truly Independent Board is Urgently Needed at Masimo in Order to Protect Shareholder Value and Realize the Company's Full Potential
Sends Letter to Masimo Shareholders and Releases 160-Page Investor Presentation Urges Shareholders to Help Deliver Immediate Change by Voting for Both of Politan's Independent and Ideally Qualified Nominees Darlene Solomon and William Jellison on the WHITE Card Shareholders Can Visit www.AdvanceMasimo.com for Further Information Politan Capital Management (together with its affiliates, "Politan"), an 8.9% shareholder of Masimo Corporation ("Masimo" or the "Company") (NASDAQ:MASI), today sent a letter to the Company's shareholders outlining why a majority of truly independent directors are urgently needed in the Masimo boardroom. Politan also released a detailed investor presentation m
6/26/24 8:00:00 AM ET
$A
$ANIK
$AVNT
$MASI
Biotechnology: Laboratory Analytical Instruments
Industrials
Medical/Dental Instruments
Health Care

$100 Invested In This Stock 10 Years Ago Would Be Worth $400 Today

Stryker's Performance Over Last 10 Years

Chat with this insight

Recent Analyst Ratings for $SYK

$SYK Press Releases

Fastest customizable press release news feed in the world

Stryker unveils Oculan Lighting Platform to enhance surgical visualization and illumination

Stryker launches next generation of SurgiCount+ to help improve the standard of care in hospitals for sponge management and blood loss assessment

Stryker reports third quarter 2024 operating results

$SYK Financials

Live finance-specific insights

Stryker reports third quarter 2024 operating results

Stryker completes acquisition of Vertos Medical, Inc., expanding interventional pain management solutions

Stryker completes acquisition of NICO Corporation, expanding minimally invasive solutions for brain tumor removal and stroke care

$SYK Market Insights

Live Market Insights

Peering Into Stryker's Recent Short Interest

$1000 Invested In Stryker 10 Years Ago Would Be Worth This Much Today

Morgan Stanley Maintains Equal-Weight on Stryker, Raises Price Target to $350

$SYK Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

$SYK Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

VP, Chief Financial Officer Boehnlein Glenn S exercised 4,500 shares at a strike of $122.51 and covered exercise/tax liability with 2,979 shares, increasing direct ownership by 53% to 4,373 units (SEC Form 4)

Group President Stiles Spencer S gifted 129 shares and sold $201,056 worth of shares (514 units at $391.16), decreasing direct ownership by 1% to 50,611 units (SEC Form 4)

Chair and CEO Lobo Kevin exercised 156,890 shares at a strike of $93.06, covered exercise/tax liability with 99,577 shares and sold $21,131,479 worth of shares (57,313 units at $368.70) (SEC Form 4)

Wolfe Research initiated coverage on Stryker with a new price target

Goldman initiated coverage on Stryker with a new price target

Stryker upgraded by Needham with a new price target

$SYK Leadership Updates

Live Leadership Updates

Masimo Appoints Timothy Scannell and Wendy Lane to Board of Directors

Eko Health Announces Appointment of Brent Lang, Former CEO of Vocera, to Board of Directors

Politan Details Why a Truly Independent Board is Urgently Needed at Masimo in Order to Protect Shareholder Value and Realize the Company's Full Potential

$SYK SEC Filings

SEC Form 10-Q filed by Stryker Corporation

Stryker Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

SEC Form CERT filed by Stryker Corporation

$SYK Large Ownership Changes

This live feed shows all institutional transactions in real time.

SEC Form SC 13G/A filed by Stryker Corporation (Amendment)

SEC Form SC 13G/A filed by Stryker Corporation (Amendment)

SEC Form SC 13G/A filed by Stryker Corporation (Amendment)

Recent Analyst Ratings for
$SYK

$SYK
Press Releases

$SYK
Financials

$SYK
Market Insights

$SYK
Insider Trading

$SYK
Analyst Ratings

$SYK
Leadership Updates

$SYK
SEC Filings

$SYK
Large Ownership Changes